Recipient gene polymorphisms in the Th-1 cytokines IL-2 and IFN-γ in relation to acute rejection and graft vascular disease after clinical heart transplantation

Transplant Immunology

Volumn 11, Issue 1, 2003, Pages 121-127

  Holweg, C T J ^a   Peeters, A M A ^a   Balk, A H M M ^a   Uitterlinden, A G ^a   Niesters, H G M ^a   Maat, A P W M ^a   Weimar, W ^a   Baan, C C ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Acute rejection; Cytokine; Gene polymorphism; Graft vascular disease; Heart transplantation

Indexed keywords

CYCLOSPORIN A; CYTOKINE; GAMMA INTERFERON; IMMUNOSUPPRESSIVE AGENT; INOLIMOMAB; INTERLEUKIN 2; OKT 3; STEROID; THYMOCYTE ANTIBODY;

ACUTE GRAFT REJECTION; ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC VARIABILITY; GENOTYPE; HEART DILATATION; HEART TRANSPLANTATION; HLA MATCHING; HUMAN; INTRON; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; POSTOPERATIVE CARE; PRIORITY JOURNAL; PROMOTER REGION; RECIPIENT; RISK FACTOR; STATISTICAL ANALYSIS; TH1 CELL; VASCULAR DISEASE;

ADULT; FEMALE; GENE FREQUENCY; GENOTYPE; GRAFT REJECTION; HEART TRANSPLANTATION; HUMANS; INTERFERON TYPE II; INTERLEUKIN-2; MALE; MIDDLE AGED; POINT MUTATION; POLYMORPHISM, GENETIC; VASCULAR DISEASES;

EID: 0038367792     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0966-3274(02)00156-9     Document Type: Article

References (31)

1. Dallman MJ. Cytokines as mediators of organ graft rejection and tolerance. Curr Opin Immunol 1993;5(5):788-793.
2. Baan CC, Weimar W. Intragraft cytokine gene expression: Implications for clinical transplantation. Transplant Int 1998;11(3):169-180.
3. Ruan XM, Qiao JH, Trento A, Czer LS, Blanche C, Fishbein MC. Cytokine expression and endothelial cell and lymphocyte activation in human cardiac allograft rejection: An immunohistochemical study of endomyocardial biopsy samples. J Heart Lung Transplant 1992;11(6):1110-1115.
4. Baan CC, Van Emmerik NE, Balk AH, et al. Cytokine mRNA expression in endomyocardial biopsies during acute rejection from human heart transplants. Clin Exp Immunol 1994;97(2):293-298.
5. Van Besouw NM, Daane CR, Vaessen LM, et al. Different patterns in donor-specific production of T-helper 1 and 2 cytokines by cells infiltrating the rejecting cardiac allograft. J Heart Lung Transplant 1995;14(5):816-823.
6. Baan CC, Holweg CT, Niesters HG, et al. The nature of acute rejection is associated with development of graft vascular disease after clinical heart transplantation. J Heart Lung Transplant 1998;17(4):363-373.
7. Van Besouw NM, Baan CC, Holweg CTJ, et al. Cytokine profiles as marker for graft vascular disease after clinical heart transplantation. Ann Transplant 2000;5(2):61-67.
8. Hoffmann SC, Stanley EM, Darrin Cox E, et al. Association of cytokine polymorphic inheritance and in vitro cytokine production in anti-cd3/cd28-stimulated peripheral blood lymphocytes 1. Transplantation 2001;72(8):1444-1450.
9. Pravica V, Asderakis A, Perrey C, Hajeer A, Sinnott PJ, Hutchinson IV. In vitro production of IFN-gamma correlates with CA repeat polymorphism in the human IFN-gamma gene. Eur J Immunogenet 1999;26(1):1-3.
10. Turner D, Grant SC, Yonan N, et al. Cytokine gene polymorphism and heart transplant rejection. Transplantation 1997;64(5):776-779.
11. Awad MR, Webber S, Boyle G, et al. The effect of cytokine gene polymorphisms on pediatric heart allograft outcome. J Heart Lung Transplant 2001;20(6):625-630.
12. Holweg CTJ, Peeters AMA, Balk AHMM, et al. The effect of HLA-DR matching on acute rejection after clinical heart transplantation might be influenced by an IL-2 gene polymorphism. Transplantation 2002;73(8):1353-1356.
13. Abdallah AN, Cucchi-Mouillot P, Biteau N, Cassaigne A, Haras D, Iron A. Analysis of the polymorphism of the tumour necrosis factor (TNF) gene and promoter and of circulating TNF-alpha levels in heart-transplant patients suffering or not suffering from severe rejection. Eur J Immunogenet 1999;26(4):249-255.
14. Bijlsma FJ, Bruggink AH, Hartman M, et al. No association between IL-10 promoter gene polymorphism and heart failure or rejection following cardiac transplantation. Tissue Antigens 2001;57(2):151-153.
15. Holweg CTJ, Baan CC, Balk AHMM, et al. TGF-β1 codon 10 gene polymorphism and accelerated graft vascular disease after clinical heart transplantation. Transplantation 2001;71(10):1463-1467.
16. Aziz T, Hasleton P, Hann AW, Yonan N, Deiraniya A, Hutchinson IV. Transforming growth factor beta in relation to cardiac allograft vasculopathy after heart transplantation. J Thorac Cardiovasc Surg 2000;119 (4 Pt 1):700-708.
17. Densem CG, Hutchinson IV, Cooper A, Yonan N, Brooks NH. Polymorphism of the transforming growth factor-beta 1 gene correlates with the development of coronary vasculopathy following cardiac transplantation. J Heart Lung Transplant 2000;19(6):551-556.
18. Billingham ME, Cary NR, Hammond ME, et al. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group. The International Society for Heart Transplantation. J Heart Transplant 1990;9(6):587-593.
19. Balk AH, Simoons ML, Van Der Linden MJ, et al. Coronary artery disease after heart transplantation: Timing of coronary arteriography. J Heart Lung Transplant 1993;12:89-99.
20. Boom R, Sol CJ, Salimans MM, Jansen CL, Wertheimvan Dillen PM, Van Der Noordaa J. Rapid and simple method for purification of nucleic acids. J Clin Microbiol 1990;28(3):495-503.
21. Livak KJ. Allelic discrimination using fluorogenic probes and the 5′ nuclease assay. Genet Anal 1999;14(5-6):143-149.
22. Reynard MP, Turner D, Navarrete CV. Allele frequencies of polymorphisms of the tumour necrosis factor-alpha, interleukin-10, interferon-gamma and interleukin-2 genes in a North European Caucasoid group from the UK. Eur J Immunogenet 2000;27(4):241-249.
23. John S, Turner D, Donn R, et al. Two novel biallelic polymorphisms in the IL-2 gene. Eur J Immunogenet 1998;25(6):419-420.
24. Marshall SE, Welsh KI. The role of cytokine polymorphisms in rejection after solid organ transplantation. Genes Immun 2001;2(6):297-303.
25. George S, Turner D, Reynard M, et al. Significance of cytokine gene polymorphism in renal transplantation. Transplant Proc 2001;33(1-2):483-484.
26. Asderakis A, Sankaran D, Dyer P, et al. Association of polymorphisms in the human interferon-gamma and interleukin-10 gene with acute and chronic kidney transplant outcome: The cytokine effect on transplantation. Transplantation 2001;71(5):674-677.
27. Pelletier R, Pravica V, Perrey C, et al. Evidence for a genetic predisposition towards acute rejection after kidney and simultaneous kidney-pancreas transplantation. Transplantation 2000;70(4):674-680.
28. Tambur AR, Ortegel JW, Ben-Ari Z, et al. Role of cytokine gene polymorphism in hepatitis C recurrence and allograft rejection among liver transplant recipients. Transplantation 2001;71(10):1475-1480.
29. Cartwright NH, Keen LJ, Demaine AG, et al. A study of cytokine gene polymorphisms and protein secretion in renal transplantation. Transplant Immunol 2001;8(4):237-244.
30. Awad M, Pravica V, Perrey C, et al. CA repeat allele polymorphism in the first intron of the human interferon-gamma gene is associated with lung allograft fibrosis. Hum Immunol 1999;60(4):343-346.
31. Baan CC, Knoop CJ, Van Gelder T, et al. Anti-CD25 therapy reveals the redundancy of the intragraft cytokine network after clinical heart transplantation. Transplantation 1999;67(6):870-876.